Technical Analysis for MYOV - Myovant Sciences Ltd.

Grade Last Price % Change Price Change
grade A 20.03 -0.60% -0.12
MYOV closed down 0.6 percent on Thursday, July 2, 2020, on 40 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical MYOV trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Multiple of Ten Bullish Other 0.00%
Wide Bands Range Expansion 0.00%
NR7 Range Contraction -0.60%
Multiple of Ten Bullish Other -0.60%
Wide Bands Range Expansion -0.60%
180 Bullish Setup Bullish Swing Setup -2.86%
Multiple of Ten Bullish Other -2.86%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for women's health diseases and other endocrine-related disorders. Its lead product candidate is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist, for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. The company also intends to develop RVT-602, an oligopeptide kisspeptin analog, for the treatment of female infertility as part of assisted reproduction. Myovant Sciences Ltd. was founded in 2016 and is based in Hamilton, Bermuda. Myovant Sciences Ltd. operates as a subsidiary of Roivant Sciences Ltd.
Chemistry Biopharmaceutical Pain Prostate Cancer Endocrine System Hormones Amines Gnrh Antagonists Pyrimidines Uterine Fibroids Gonadotropin Releasing Hormone Antagonist Roivant Sciences Uterine Fibroid

Is MYOV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 22.07
52 Week Low 4.15
Average Volume 1,422,887
200-Day Moving Average 11.44
50-Day Moving Average 15.02
20-Day Moving Average 18.25
10-Day Moving Average 19.58
Average True Range 1.36
ADX 48.4
+DI 28.74
-DI 11.24
Chandelier Exit (Long, 3 ATRs ) 17.99
Chandelier Exit (Short, 3 ATRs ) 19.63
Upper Bollinger Band 21.57
Lower Bollinger Band 14.93
Percent B (%b) 0.77
BandWidth 36.44
MACD Line 1.60
MACD Signal Line 1.56
MACD Histogram 0.0453
Fundamentals Value
Market Cap 1.22 Billion
Num Shares 60.8 Million
EPS -1.63
Price-to-Earnings (P/E) Ratio -12.29
Price-to-Sales 0.00
Price-to-Book 5.51
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.95
Resistance 3 (R3) 20.98 20.71 20.79
Resistance 2 (R2) 20.71 20.48 20.69 20.74
Resistance 1 (R1) 20.37 20.33 20.24 20.34 20.69
Pivot Point 20.10 20.10 20.03 20.08 20.10
Support 1 (S1) 19.76 19.87 19.63 19.73 19.37
Support 2 (S2) 19.49 19.72 19.47 19.32
Support 3 (S3) 19.15 19.49 19.27
Support 4 (S4) 19.12